Your browser doesn't support javascript.
loading
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.
Campling, James; Vyse, Andrew; Liu, Hui-Hsuan; Wright, Hannah; Slack, Mary; Reinert, Ralf-Rene; Drayson, Mark; Richter, Alex; Singh, Dave; Barlow, Gavin; Kassianos, George; Ellsbury, Gillian.
Afiliação
  • Campling J; Medical Affairs, Pfizer Ltd, Walton Oaks, UK.
  • Vyse A; Medical Affairs, Pfizer Ltd, Walton Oaks, UK.
  • Liu HH; Real-World Evidence, OPEN Health, London, UK.
  • Wright H; Medical Affairs, Pfizer Ltd, Walton Oaks, UK.
  • Slack M; School of Medicine & Dentistry, Griffith University, Southport, Queensland, Australia.
  • Reinert RR; Medical Affairs, Pfizer Inc, Pfizer, Paris, France.
  • Drayson M; Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK.
  • Richter A; Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK.
  • Singh D; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Barlow G; Hull York Medical School, University of York, York, UK.
  • Kassianos G; Royal College of General Practitioners, London, UK.
  • Ellsbury G; British Global & Travel Health Association, Bath, UK.
Expert Rev Vaccines ; 22(1): 785-800, 2023.
Article em En | MEDLINE | ID: mdl-37694398

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Cobertura Vacinal Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Expert Rev Vaccines Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Cobertura Vacinal Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Expert Rev Vaccines Ano de publicação: 2023 Tipo de documento: Article